How Many Injections for Ozempic: Understanding Your Dosage and Treatment Plan

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections deliver consistent weekly doses that help regulate appetite and blood sugar, with most patients starting at 0.25 mg and advancing based on tolerance and response. Understanding your injection schedule and how your dose evolves over months is key to maximizing results while minimizing side effects. PlexusDx provides personalized semaglutide therapy from licensed 503A compounding pharmacies across all 50 states.

How Semaglutide Injection Dosing Works

Semaglutide comes as a once-weekly injectable medication that activates GLP-1 receptors in your brain and pancreas. The typical starting dose is 0.25 mg, which is the smallest strength needed to allow your body to adapt to the medication's effects. Your healthcare provider increases your dose incrementally—usually by 0.25 mg every four weeks—until you reach a therapeutic level that works for your weight and metabolic goals.

Most patients reach a maintenance dose between 1.0 mg and 2.4 mg weekly, though some respond well at lower doses while others benefit from the maximum. The gradual escalation reduces nausea, vomiting, and gastrointestinal side effects that can occur when doses increase too quickly. Your individual dose depends on factors like starting weight, metabolic rate, and how your body responds to each increment.

Standard Semaglutide Injection Dosing Schedule

The traditional four-week titration protocol moves patients from 0.25 mg to 0.5 mg to 0.75 mg to 1.0 mg over 16 weeks, with the option to continue increasing beyond that point. Each weekly injection delivers the same dose until your provider adjusts it, making adherence straightforward and predictable. Some patients pause at 1.0 mg if they achieve their weight loss and appetite-control goals, while others advance to 1.5 mg, 2.0 mg, or 2.4 mg for stronger effects.

Clinical trials show that dose escalation improves weight loss outcomes, with patients on higher doses achieving greater body weight reductions over 68 weeks of treatment. However, higher doses also increase the likelihood of gastrointestinal side effects like nausea or constipation. Your provider will work with you to find the optimal dose that balances efficacy with tolerability.

Factors That Influence Your Personal Dosing Plan

Your individual dosing trajectory depends on your starting metabolic profile, kidney function, gastrointestinal tolerance, and weight loss response. Patients with a history of pancreatitis, severe gastrointestinal disease, or certain endocrine conditions may require slower titration or lower maximum doses. Age, existing medications, and body composition also shape how quickly your provider advances your dose and whether you plateau at a lower level.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Semaglutide Injections: Access and Affordability

PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies to all 50 states without requiring insurance or membership fees. Your dose may advance as your treatment progresses, but your monthly price remains flat at just $149—a straightforward model designed so you never pay more as your dose increases. This flat-rate structure removes the financial barrier to optimizing your therapy.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide, and how often do I inject it?

The standard starting dose is 0.25 mg injected once weekly under the skin. Your dose increases by 0.25 mg every four weeks as tolerated, with most patients reaching a maintenance range of 1.0 to 2.4 mg weekly. PlexusDx delivers your prescribed dose each month from a licensed 503A compounding pharmacy.

How long does it take to reach my target semaglutide dose?

Following the standard four-week escalation protocol, reaching 1.0 mg takes approximately 16 weeks. If you continue titrating to 1.5 mg, 2.0 mg, or 2.4 mg, you'll add another 4 to 16 weeks depending on your tolerance and response. Some patients stabilize at lower doses and never advance beyond 0.75 mg or 1.

Does my monthly price increase when my semaglutide dose goes up?

No. PlexusDx charges a flat monthly rate of $189 for semaglutide injections regardless of your dose level—whether you're at 0.25 mg or 2.4 mg. The pricing model ensures your cost stays predictable as your treatment advances.

What side effects should I expect during semaglutide dose escalation?

The most common side effects during titration are nausea, vomiting, constipation, and reduced appetite—effects that often decrease over time as your body adjusts. More serious but rare side effects include pancreatitis and gallbladder issues.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The PlexusDx Precision Peptide Genetic Test analyzes variants in GIPR and FTO, and MC4R genes that influence your individual response to semaglutide. These insights help your provider tailor your starting dose and escalation pace to your unique peptide biology. The test is $298.

Related Reading

• Mark Longevity Physician Approved Treatment Plan
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.